STATEN ISLAND, N.Y. — When Staten Islander Deana Jean discovered a lump in her breast during her third pregnancy, she had no ...

With breast cancer emerging as the most prevalent type of cancer in Indian women, it becomes crucial to understand what is ...

Adjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved invasive disease-free survival compared with ...

Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by ...

Almost immediately after Theresa Greco was diagnosed with breast cancer in March, doctors asked her whether she wanted to ...

In HR+/HER- early breast cancer, the DFS benefits of adjuvant ribociclib plus NSAI treatment compared to NSAI alone persisted even a year after treatment completion.

Following the blood test at 10 weeks, "everything unfolded in what felt like a blink of an eye" for Victoria Glass.

About 60% women in Europe enrolled in a national breast cancer screening programme who have a screening mammogram can feel reasonably confident that radiologists will be able to diagnose early-stage ...

Just a year after being diagnosed with breast cancer, and following three surgeries, 15 hours of radiation treatments and ...

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and ...

Researchers present an overview of treatment and management strategies for patients with HR+/HER2+ breast cancer, including common adverse effects.